Organisation · Unternehmen
Amgen Inc
amgen-inc-eutr-57523750
Aussagen (8)
eu transparency category
Companies & groups
dokumentiert
[Q-20951]
eu transparency goals
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987. Amgen has a presence in approximately 100 countries worldwide. It operates in one business segment : human therapeutics.
dokumentiert
[Q-20951]
eu transparency id
42243575237-50
dokumentiert
[Q-7535]
headquarters city
Thousand Oaks, California
dokumentiert
[Q-20951]
headquarters country
GB
dokumentiert
[Q-20951]
interest class
business_company
dokumentiert
[Q-29773]
legal form
Corporation
dokumentiert
[Q-20951]
legal form class
ausland_sonstig
berichtet
[Q-29773]